Citi has exited neobanking software developer Digit and real estate analytics provider Reonomy in acquisitions each sized at over $200m.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.

Prosus Ventures took part in the D2C brand acquirer’s third round this year, valuing it at above $1bn and boosting its overall equity and debt financing to over $300m.

BMW and Bridgestone-backed autonomous truck technology developer increased its overall funding to $165m in its latest round.

NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.

Animoca Brands, Warner Music Group, OverWolf, Playstudios, Huuuge, Cosmos, Polygon Studios and Solana all contribuetd to the blockchain gaming developer's series B round.

Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.

Alexandria Venture Investments was among the participants in a series B round which will support clinical trials for Acrivon's lead oncology drug candidate.

Existing investors Lilly Asia Ventures and SBCVC returned for the multiomics product developer's latest round, in which it raised nearly $100m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.